Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay

Coelho, T., Dispenzieri, A., Grogan, M., Conceição, I., Waddington-Cruz, M., Kristen, A. V., Wixner, J., Diemberger, I., Gonzalez-Moreno, J., Maurer, M. S., Planté-Bordeneuve, V., Garcia-Pavia, P., Tournev, I., Gonzalez-Costello, J., Cariou, E., González-Duarte, A., Glass, O., Chapman, D., … Amass, L. (2023). Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay. Amyloid, 30(4), 445–448. https://doi.org/10.1080/13506129.2023.2229484
Authors:
Teresa Coelho
Angela Dispenzieri
Martha Grogan
Isabel Conceição
Márcia Waddington-Cruz
Arnt V Kristen
Jonas Wixner
Igor Diemberger
Juan Gonzalez-Moreno
Mathew S Maurer
Violaine Planté-Bordeneuve
Pablo Garcia-Pavia
Ivailo Tournev
Jose Gonzalez-Costello
Eve Cariou
Alejandra González-Duarte
Oliver Glass
Doug Chapman
Leslie Amass
Affiliated Authors:
Mathew S Maurer
Publication Type:
Article
Unique ID:
10.1080/13506129.2023.2229484
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: